Malate dehydrogenase (MDH) has been used as a conjugate for enzyme immunoassay of a wide variety of compounds, such as drugs of abuse, drugs used in repetitive therapeutic application and hormones. In consideration of the various biotechnological applications of MDH, investigations of MDH from Thermus thermophilus were carried out to further understand the properties of this enzyme. The DNA fragment containing the open reading frame of mdh was amplified from the genomic DNA of T. thermophilus and cloned into the expression vector pET21b(+). The protein was expressed in a soluble form in Escherichia coli strain BL21(DE3). Homogeneous protein was obtained using a three-step procedure consisting of thermal treatment, Ni 2+ -chelating chromatography and size-exclusion chromatography. The purified MDH was crystallized and the crystals diffracted to a resolution of 1.80 Å on the BL13C1 beamline of the National Synchrotron Radiation Research Center (NSRRC), Taiwan. The crystals belonged to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 71.3, b = 86.1, c = 118.2 Å . The unit-cell volume of the crystal is compatible with the presence of two monomers in the asymmetric unit, with a corresponding Matthews coefficient V M of 2.52 Å 3 Da À1 and a solvent content of 51.2%. The crystal structure of MDH has been solved by molecular replacement and is currently under refinement.
Introduction
Malate dehydrogenase (MDH; EC 1.1.1.37), an enzyme involved in the TCA cycle and the malate-aspartate shuttle, plays important roles in glucose metabolism and energy generation (Miná rik et al., 2002; Sundaram et al., 1980) . MDH catalyzes a dehydrogenation reaction from malate to generate oxaloacetate, accompanied by the reduction of NAD to generate NADH (Frieden & Fernandez-Sousa, 1975) . The overall reaction catalyzed by MDH is reversible; therefore, the activity of MDH can easily be measured by detecting the decreasing amount of NADH. The convenient measurement method enables MDH to be applied in coupling assays for measuring the activities of enzymes whose product is oxaloacetic acid, such as activity assays of aspartate aminotransferase and aspartate oxidase. MDH is also used in medical biotechnology for enzyme immunoassay of a wide variety of compounds, such as drugs of abuse, drugs used in repetitive therapeutic application and hormones (Li et al., 1996) .
Although numerous thermophilic MDHs have been characterized, the structure of the enzyme without co-substrate binding and the molecular basis of the action mode at high temperature are still poorly understood. In consideration of the various applications of MDH, investigations of MDH from Thermus thermophilus were carried out to understand the structure-function relationship of this enzyme. Elucidation of the molecular architecture for future protein engineering on the enzyme's activity and thermostability would also be accomplished simultaneously. Here, we report the cloning, overexpression, purification and crystallization of malate dehydrogenase from T. thermophilus. In addition, the crystal structure of MDH has been solved by molecular replacement and is currently under refinement.
Experimental methods

Cloning
The mdh (malate dehydrogenase; UniProt accession No. P10584) gene was PCR-amplified using gene-specific primers (forward primer, 5 0 -GTG GCA TAT GAA GGC ACC CGT ACG CGT GG-3 0 ; reverse primer, 5 0 -TCT GAG GCA AAG CTT TCG GAT GAG GCC CAG GG-3 0 ) and the genomic DNA of T. thermophilus HB8 genomic DNA as a template. The amplified DNA fragment flanked by NdeI and HindIII sites (bold) was cloned into the pGEM-T Easy vector (Promega, USA). Recombinant plasmids were introduced into Escherichia coli JM109 by transformation. Plasmid DNA was isolated from the transformants and digested with NdeI and HindIII and the fragment was then cloned into pET21b(+) (Novagen) linearized with the same restriction enzymes. The identity of the gene was confirmed by sequencing the clone using Sanger's method.
Overexpression
The expression vector containing the mdh gene fragment was introduced into the E. coli BL21(DE3) strain. 10 ml of an overnight culture of each recombinant clone was inoculated into Luria-Bertani medium containing 100 mg l À1 ampicillin; the culture was grown at 310 K with shaking at 200 rev min À1 to an OD 600 of 1.0. Isopropyl -d-1-thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM to induce protein expression and the cultures were incubated for a further 2 h at 310 K. The cells were harvested by centrifugation at 9000g for 30 min.
Purification
The cell pellet was resuspended in resuspension buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 10 mM imidazole) and disrupted by ultrasonication. The cell debris was removed by centrifugation at 20 000g for 20 min at 277 K. The supernatant was further treated at 343 K for 30 min and centrifuged at 20 000g for 20 min at 277 K to remove the denatured proteins. The protein was purified from the supernatant by Ni 2+ -charged HiTrap chelating FF column chromatography (GE Healthcare, USA) in a buffer system consisting of 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 200 mM imidazole. Fractions containing T. thermophilus MDH (TtMDH) were pooled and dialyzed against 50 mM Tris-buffered solution pH 8.0 containing 150 mM NaCl. The protein was further purified by size-exclusion chromatography using a Superdex S-200 HR10/300 column preequilibrated with size-exclusion buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 5 mM EDTA) on an Ä KTA FPLC system (GE Healthcare, USA). The purity of the TtMDH protein was monitored and appeared as a single band on SDS-PAGE (Fig. 1a ). The protein concentration was determined by measuring the absorbance at 280 nm under denaturing conditions using a UV-Vis spectrometer (Hitachi, Japan). The predicted extinction coefficient based on the amino-acid sequence of the final protein construct (Gill & von Hippel, 1989 ) was 32 430 M À1 cm À1 . Prior to crystallization, the purified protein was concentrated to 10.0 mg ml À1 using a Centricon membrane filter (30 kDa cutoff, Millipore, USA). No His-tag removal was attempted.
Crystallization
Crystallization was performed by the vapour-diffusion method using a HoneyBee 963 robot (Genomic Solutions). Sitting drops were prepared by mixing 0.5 ml TtMDH solution at 10 mg ml À1 with an equal volume of reservoir solution and were equilibrated against 100 ml reservoir solution at 283 K. Small crystals grew from a solution consisting of 0.1 M Tris-HCl pH 8.5, 30%(w/v) polyethylene glycol 4000, 0.2 M magnesium chloride. The crystals were then optimized manually by varying the pH or precipitant concentration in small steps. The best crystals grew in 5 d from a solution consisting of 0.1 M Tris-HCl pH 8.2, 22.5%(w/v) polyethylene glycol 4000, 0.2 M magnesium chloride, 5%(v/v) glycerol (Fig. 1b) .
X-ray data collection and processing
Data collection was accomplished using a synchrotron-radiation X-ray source on protein crystallographic beamline BL13C1 equipped with the ADSC Quantum 315r CCD detector at the National the HKL-2000 program suite (Otwinowski & Minor, 1997) . The orthorhombic space group P2 1 2 1 2 1 was derived by auto-indexing, with unit-cell parameters a = 71.3, b = 86.1, c = 118.2 Å . A complete data set was obtained to 1.80 Å resolution, corresponding to an R merge of 6.1%. Details of the data-collection statistics are summarized in Table 1 .
Results and discussion
Assuming the presence of one dimer in the crystallographic asymmetric unit, the Matthews coefficient V M (Matthews, 1968) and solvent content were calculated as 2.52 Å 3 Da À1 and 51.2%, respectively, based on a subunit of molecular weight 37 kDa. The BALBES program (Long et al., 2008) was used for molecular-replacement calculation with T. flavus MDH (PDB entry 1bmd; Kelly et al., 1993) as a search model and REFMAC5 (Murshudov et al., 2011) was used for refinement. The R work of the unrefined structure was found to be 33.8%. Examination of the molecular-replacement solution structure revealed good crystal packing and no clashes with the symmetryrelated molecules. The initial A -weighted electron-density map with 2F o À F c Fourier coefficients and molecular-replacement phases was of interpretable quality almost throughout the chain. This preliminary model is currently being refined. TtMDH cocrystallization or soaking with substrates is under way. 
